Overton’s nomination withdrawal means no clear end for FDA leadership vacuum
The White House abruptly withdrew Heidi Overton's nomination to lead the FDA, leaving the agency without permanent leadership since Commissioner Marty Makary stepped down in May, with Deputy Commissioner Kyle Diamantis serving as acting commissioner. Senator Patty Murray was blocking Overton's confirmation over her criticism of the abortion pill mifepristone, and CNN reported, citing sources, that her clashes with Health and Human Services Secretary Robert F. Kennedy Jr. were the nail in the coffin for the nomination. The withdrawal caught senators and senior health officials off guard, and the White House has offered no new names while Senator Bill Cassidy says confirming a permanent commissioner will now fall to Senate Democrats. NewsNation reports the FDA could remain without a permanent leader into 2027.
The MAGA Crackup Around the Corner
Andrew Egger's Bulwark article argues Donald Trump's MAGA coalition is splintering, citing the Senate's killing of T. Elliott Gaiser's judgeship nomination and Trump's withdrawal of Heidi Overton's FDA nomination over a mifepristone dilemma the article says could explode into a coalition-shaking controversy in 2027. It also notes the administration dropped its suit against Mary Peltola's Alaska Senate win, and gathers other items, from John Cornyn's shouted rift with Ted Cruz to Jason Miller's undisclosed $15 million as a registered foreign agent.
Trump's 'surprise move' blindsides his own officials — and draws fire from key GOP senator
The White House abruptly dropped Heidi Overton, Trump's pick to lead the FDA, blindsiding senior health officials just hours after her team thought it had won over Sen. Josh Hawley with commitments on the review of mifepristone. Per CNN, her allies say she had the votes and suspect Robert F. Kennedy Jr. and new chief of staff Stephen Miller soured on her; Sen. Bill Cassidy, who was livid, writes on X that confirming a permanent FDA Commissioner will now fall to Senate Democrats.
Sudden withdrawal of Trump’s FDA pick blindsided officials and left key senator fuming | CNN Politics
CNN Politics reports that the White House abruptly withdrew Dr. Heidi Overton's FDA nomination hours after her team believed she had secured Senate support, blindsiding senior health officials and angering Senator Bill Cassidy, who says confirming a permanent commissioner will now fall to Democrats. The FDA has lacked a permanent chief since May.
Trump abandons his FDA nominee, and Senate scraps vote on his NSF pick
In under 24 hours, two Trump nominees went down: the White House abruptly withdrew Heidi Overton's FDA nomination after Axios reported she lacked support on the Hill, and the Senate HELP committee scrapped its vote on Jim O'Neill for the National Science Foundation. Overton had stonewalled senators at her hearing on vaccines, abortion, and mifepristone; Cassidy cited O'Neill's role in Susan Monarez's ouster as CDC director.
Cassidy slams White House for pulling FDA nominee who ‘probably had the votes’
POLITICO's Inside Congress Live leads with Sen. Bill Cassidy criticizing the Trump administration for abruptly pulling FDA nominee Heidi Overton hours before her confirmation vote — he said she "probably had the votes," called the administration "an unserious regime," and predicted Democrats will likely choose the next FDA leader. It also covers the canceled vote on Jim O'Neill's NSF nomination, Dick Durbin's grilling of judicial nominees tied to the James Comey case, Brett Guthrie's Nvidia export probe, Katherine Clark and Hakeem Jeffries winning House Democratic leadership posts, the FCC nominee advanced over a Democratic boycott, and Wes Moore's call to end the Iran war while keeping the government open.
'This was odd': GOP senator blows up White House's overnight story on ditched nominee
RawStory reports that the White House pulled Dr. Heidi Overton's FDA nomination the night before her committee vote, and Senator Bill Cassidy publicly disputed its stated reason, writing that the administration withdrew her rather than give pro-life senators commitments and that he believed she had the votes. Cassidy also said confirming a permanent commissioner will now fall to Senate Democrats.
Trump's pick Heidi Overton dropped as nominee for FDA commissioner
Arthur L. Jones II reports for abcnews.com that the White House dropped Dr. Heidi Overton's nomination to lead the FDA, an agency that had lacked a permanent leader for nearly seven months. Nominated by President Trump in August 2026, Overton had drawn bipartisan Senate concerns over her stances on abortion, vaccines, and vaping, and Sen. Bill Cassidy said the withdrawal came over anti-abortion senators' demands for assurances.
Trump withdraws Heidi Overton as nominee to lead Food and Drug Administration, sources say
Citing Reuters sources, CNBC reports that Donald Trump withdrew Heidi Overton's nomination to lead the FDA over insufficient support in Congress, one day before her Senate committee vote. The White House is weighing Kansas Senator Roger Marshall as a replacement, after midterm losses and opposition over her vaccination and mifepristone stances.
White House pulls Heidi Overton's FDA nomination ahead of Senate panel vote
USA TODAY reports that the White House pulled Dr. Heidi Overton's nomination to lead the FDA on November 17, 2026, the day before a Senate committee vote, leaving the Trump administration searching for a new FDA leader. The article says she lacked the votes, with Democrats expected to oppose her after senators questioned her on vaccine policy, and notes the agency has lost more than 3,000 employees.
White House Withdraws Nomination of Heidi Overton to Be F.D.A. Commissioner
A New York Times article reports that the White House pulled Dr. Heidi Overton's nomination to be F.D.A. commissioner on the eve of a crucial Senate panel vote, after it became clear she lacked the votes. Senators had pressed her on vaccines and were alarmed by her past statements on the abortion pill mifepristone.
White House drops Heidi Overton’s FDA nomination after Republicans raise concerns
The White House withdrew Dr. Heidi Overton's FDA nomination on Nov. 17, 2026, a day before her Senate Health Committee vote, amid Republican concerns over her experience and refusal to give pro-life senators assurances on life issues. Sen. Bill Cassidy, who had questioned her managerial experience, said confirmation of a permanent commissioner will now fall to Senate Democrats.
White House pulls FDA pick over lack of support
The White House pulls Heidi Overton's nomination to lead the FDA over insufficient Republican support ahead of a Senate health committee vote, with several GOP senators undecided after a September hearing that left key backers unpersuaded. Former Trump aide Calley Means accuses her of undermining the "Make America Healthy Again" agenda.
White House drops Trump’s FDA pick amid senators’ opposition and ‘icy’ relationship with RFK Jr. | CNN Politics
The White House abruptly pulled Dr. Heidi Overton's nomination to lead the FDA the night before a Senate committee vote, capping weeks of opposition from Republican senators and activists aligned with HHS Secretary Robert F. Kennedy Jr., including anger over flavored vapes and abortion policy. Sen. Bill Cassidy wrote that the White House "abandoned a viable confirmation path" for Overton and withdrew her rather than give pro-life senators commitments, while Sen. Roger Marshall, an ardent MAHA supporter, has expressed interest in the role.
White House Abandons Trump’s Pick to Lead the FDA
The Trump administration is withdrawing Dr. Heidi Overton's nomination to lead the FDA, according to people familiar with the matter, amid signs she lacked the Senate support to be confirmed. GOP lawmakers on the Senate panel weighing her nomination had raised concerns about her views on vaccine recommendations, vape restrictions, and abortion policy.
